Lyell to Highlight Vision for its Next-Generation CAR
Accelerating IMPT-314 in large B-cell lymphoma; remain on track to initiate pivotal trial in the 3rd line+ setting in 2025...
CAR
Immuneel Therapeutics launches global CAR T-cell therapy for Non-Hodgkin’s Lymphoma in India – Healthcare News
Immuneel Therapeutics on Monday launched Qartemi, a CAR T-cell therapy for adult B-cell Non-Hodgkin Lymphoma (B-NHL). According to the company’s...
Addressing Disparities in CAR T-Cell Therapy Access for Minority Patients with Large B-Cell Lymphomas
A recent study published in March 2024 in NEJM Evidence, led by senior author Marco Ruella, M.D., assistant professor of...
